Home Your basket
• Cervicofacial cellulitise...
   Price 10.50 €
• Contribution of endoscopi...
   Price 8.50 €
• Ectopic thyroid basi-ling...
   Price 10.50 €
• Giant laryngeal sarcomato...
   Price 12.00 €
• Acquired non tumoral lary...
   Price 12.00 €
• Social integration 15 yea...
   Price 14.00 €
• Evaluation of a dysphonic...
   Price 10.50 €
• Autistic like behaviour d...
   Price 8.50 €
• Vocal effectiveness in sp...
   Price 10.50 €
• Thyroid pseudo-nodules: 3...
   Price 5.50 €
• Endovascular treatment of...
   Price 12.00 €
• Rhinophyma in a black afr...
   Price 5.50 €
• Floating stapes footplate...
   Price 12.00 €
• Dysphonia in children: Re...
   Price 12.50 €
• Training strategies of th...
   Price 8.50 €
• Thyroid tuberculosis asso...
   Price 5.50 €
• Aspects of ageing on prof...
   Price 12.00 €
• Validation of a self-asse...
   Price 10.50 €
• Arteriovenous haemangioma...
   Price 8.50 €
• Influence of the relapse ...
   Price 10.50 €
• Positioning in the oropha...
   Price 8.50 €
• Acute mesenteric ischemia...
   Price 5.50 €
• Evaluation of quality of ...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• How to manage post staped...
   Price 5.50 €
• Thyroid papillary microca...
   Price 10.50 €
• Non-functioning parathyro...
   Price 5.50 €
• Congenital anomalies of n...
   Price 14.00 €
• Role of diffusion weighte...
   Price 10.50 €
• Benign positional vertigo...
   Price 8.50 €
• The infrahyoid musculocut...
   Price 10.50 €
• Sinonasal malignant schwa...
   Price 5.50 €
• The «intra-cordal polyp»:...
   Price 5.50 €
• Hearing aids rehabilitati...
   Price 12.50 €
• Value of the preservation...
   Price 14.00 €
• Difficult blepharoplastie...
   Price 10.50 €
• The verrucous laryngeal c...
   Price 5.50 €
• Medical rhinoplasty: Rati...
   Price 10.00 €
• Bullet in the pharynx: En...
   Price 10.50 €
• Bilateral cochlear implan...
   Price 5.50 €
• Advantages of combined th...
   Price 10.50 €
• Rhinolithiasis: Review ab...
   Price 5.50 €
• Revision ossiculoplasty: ...
   Price 10.50 €
• Diagnosis and treatment o...
   Price 10.50 €
• Guidelines for the clinic...
   Price 12.00 €
• From intelligibility to c...
   Price 10.50 €
• Treatment of severe epist...
   Price 5.50 €
• Middle ear osteoma: A rar...
   Price 8.50 €
• Pleomorphic adenoma of th...
   Price 12.00 €
• Active bone conduction im...
   Price 12.00 €
• Laryngeal papillomatosis ...
   Price 5.50 €
• Karapandzic flap for reco...
   Price 10.50 €
• Posterior cranial fossa a...
   Price 8.50 €
• Understanding the use of ...
   Price 10.50 €
• Esophageal foreign body: ...
   Price 5.50 €
• The input of autogenous g...
   Price 10.50 €
• Audiological comparison b...
   Price 14.00 €
• Vestibular neuritis: aeti...
   Price 8.50 €
• An original case of laryn...
   Price 8.50 €
• Traditional and emerging ...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• The tensegrity concept ap...
   Price 10.50 €
• Benign paroxysmal positio...
   Price 5.50 €
• Minimising radiation dose...
   Price 5.50 €
• An unusual cause of neona...
   Price 5.50 €
• Unilateral laryngeal para...
   Price 10.50 €
• Middle ear tuberculosis e...
   Price 5.50 €
• Electrorhinomanometric ev...
   Price 10.50 €
• The eye movement autophon...
   Price 14.00 €
• Fronto-ethmoidal mucocele...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €

Total Order 663.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2000 o

RHINOLOGY

Acceptability of topical administration of a combination of corticoid (beclomethasone) and antihistamine (azelastine) in the treatment of allergic rhinitis.


Authors : D. Portmann, M. Le Gal, V. Jessent, J.-L. Verrière (Bordeaux, Lyon)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,4:273-280.

Article published in french
Downloadable PDF document french



Summary : A prospective multicentre study involving 219 patients with seasonal or aperiodic rhinitis was performed to assess the acceptability of a local treatment combining antihistamine (azelastine) and corticoid (beclomethasone) drugs. The drugs were administered either together (morning and evening, with a 5-minute interval) or separately (azelastine in the morning and evening, and beclomethasone later during the morning and in the afternoon) for 15 days. Treatment acceptability was measured by a nine-fold questionnaire (7-point scale, mean score per question). Patient participation, protocol and therapy compliance, and treatment efficacy and tolerance were also studied. The acceptability of the association was satisfactory (mean score for general facility of treatment: 4.7 / 6) and did not differ between administration schedules. Patients found treatment easy, and were not bothered by the bulk of the bottles or the risk of mixing them up. This acceptability was confirmed by the low percentage (4 %) of patients refusing to be included in the study (refusing any treatment by nasal spray). The general acceptability was confirmed by the results for therapy compliance, general efficacy and tolerance: 94.9 % of the patients took more than 75 % of the administrations prescribed, 77.6 % of the patients and 85.2 % of the practitioners judged treatment efficacy as good or excellent, and 84.6 % of the patients and 91.4 % of the practitioners judged tolerance as good or excellent. Moreover, most of the adverse events consisted of minor signs of local intolerance, and were identical to those observed when the two treatments were administered alone.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE